HQL — abrdn Life Sciences InvestorsToday's name, from the SEC's present-day ticker list — a present-day mapping, not the name as of each filing.
- Congress trades
- 9
- all time
- Members · 12m
- 0
- 0 buys · 0 sells · by trade date
- Latest filing
- 11-03
- 2022-11-03
- Rows filed past the STOCK Act's 45-day window, stated on the row, never editorialised; both dates and the receipt stay on every row.
- 0
- every row filed inside 45 days
- 13F holders
- —
- issuer resolved · no holder rows
Congress · disclosure timeline
By trade date · 24 months · 0 rows ▲ buy, ▼ sell; height = lower bound (log scale). Trade date, not filing date — the filing lag is in the table below.No dated HQL rows fall inside the trailing 24 months by trade date.
Members active in HQL
12 months · most active first Rows = number of disclosures, not dollars. Net = lower bound of the net range. Committees as of each member's latest trade in the window (roster snapshot 2026-10-29).No member disclosed HQL in the trailing 12 months.
| Filed | Member | Side · Owner | Traded · Lag | Amount | Range · Flags | Src |
|---|---|---|---|---|---|---|
| 2022-11-03 | Thomas R. Carper D–DE | SELL SP (spouse-owned) | Traded 10-04 +30d | $1K–$15K | ||
| 2020-03-03 | Thomas R. Carper D–DE | BUY SP (spouse-owned) | Traded 02-22 +10d | $1K–$15K | ||
| 2020-03-03 | Thomas R. Carper D–DE | BUY SP (spouse-owned) | Traded 02-22 +10d | $1K–$15K | ||
| 2016-09-28 | Raúl M. Grijalva D–AZ-7 | SELL SP (spouse-owned) | Traded 09-19 +9d | $1K–$15K | ||
| 2016-03-03 | Raúl M. Grijalva D–AZ-7 | BUY SP (spouse-owned) | Traded 02-12 +20d | $1K–$15K | ||
| 2016-02-08 | Raúl M. Grijalva D–AZ-7 | BUY SP (spouse-owned) | Traded 01-13 +26d | $1K–$15K | ||
| 2015-11-02 | Raúl M. Grijalva D–AZ-7 | BUY SP (spouse-owned) | Traded 10-15 +18d | $1K–$15K | ||
| 2015-08-13 | Raúl M. Grijalva D–AZ-7 | SELL SP (spouse-owned) | Traded 07-14 +30d | $1K–$15K | ||
| 2014-03-03 | Raúl M. Grijalva D–AZ-7 | BUY SP (spouse-owned) | Traded 02-21 +10d | $1K–$15K |
Institutional holders · 13F
Mapped, but not in the published aggregate.
HQL resolves to abrdn Life Sciences Investors (CIK 884121), but this build's aggregate holds no entity-keyed top-holder rows for it. HQL on SEC EDGAR ↗
Crowding — not available in this build. The ticker resolves to abrdn Life Sciences Investors (CIK 884121), but this build's aggregate holds no entity-keyed holder rows for it — its 13F securities are provisional identities without a CUSIP→issuer bridge — so it cannot be ranked among tracked names.
Congress ↔ notable managers · HQL
Congress · last 90 days
- Buyers
- 0 — —
- Sellers
- 0 — —
filed 2026-07-31 → 2026-10-29 · statutory ranges
Notable managers
Not available for HQL: the reviewed 13F name-and-class mapping does not name this ticker yet, so no notable manager's holding of it can be read. how tickers are mapped ↗
No moves on either side in the window.